Ann Clin Microbiol 2023;26:29-36. Risk factors associated with colistin-resistant Acinetobacter baumannii infection
Table 1. Antimicrobial resistance of colistin-resistant A. baumannii and colistin-susceptible A. baumannii groups
Antimicrobial Colistin-resistant group (n=51) Colistin-susceptible group (n =100) P-value
No. (%) No. (%)
Amikacin 45 (88.2) 55 (55.0) 0.000
Ampicillin/sulbactam 33 (64.7) 51 (51.0) 0.000
Cefepime 47 (92.2) 60 (60.0) 0.000
Cefotaxime 50 (98.0) 60 (60.0) 0.000
Ceftazidime 47 (92.2) 60 (60.0) 0.000
Ciprofloxacin 46 (90.2) 58 (58.0) 0.000
Gentamicin 46 (90.2) 56 (56.0) 0.000
Imipenem 51 (100.0) 58 (58.0) 0.000
Meropenem 48 (94.1) 59 (59.0) 0.000
Minocycline 23 (45.1) 25 (25.0) 0.004
Piperacillin 49 (96.1) 62 (62.0) 0.000
Ticarcillin/Clavulanic 48 (94.1) 59 (59.0) 0.000
Trime thoprim/sulfamethoxazole 44 (86.3) 55 (55.0) 0.000